Universe · entity
CAXTON CORP
Institutional manager (13F) · CIK 1388551
13F holdings · as of 2026-03-31 · top 7 · reported portfolio $4M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | SPDR GOLD TR | $3M | 7,623 |
| 2 | BERKSHIRE HATHAWAY INC DEL | $348k | 727 |
| 3 | KYVERNA THERAPEUTICS INC | $162k | 18,773 |
| 4 | LEXEO THERAPEUTICS INC | $80k | 13,943 |
| 5 | X4 PHARMACEUTICALS INC | $64k | 15,557 |
| 6 | INHIBIKASE THERAPEUTICS INC | $48k | 28,453 |
| 7 | ALX ONCOLOGY HLDGS INC | $42k | 20,946 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.